Beam Therapeutics Cofounder And Crispr Scientist Publishes Research On New Sickle Cell Treatment In Mice June 2, 2021
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology’s Medical Journal “Blood” June 2, 2021
Verve Therapeutics Appoints Leading Biotechnology Executive Michael MacLean to its Board of Directors June 1, 2021
Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships June 1, 2021
Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo June 1, 2021
Innovaccer Partners With PatientPing to Empower Physicians With Real-Time Care Coordination June 1, 2021
AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib in Greater China May 31, 2021
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 May 27, 2021
NFlection Therapeutics’ NFX-179 Gel Demonstrates Safety and Significant Reduction in p-ERK, a Key Biomarker Driving Neurofibroma Tumor Growth, in Positive Data From a 28-Day Phase 2a Clinical Trial May 26, 2021